标题
The Impact of COVID-19 on the Optimal Management of Osteoporosis
作者
关键词
-
出版物
Journal of Bone Metabolism
Volume 28, Issue 2, Pages 115-122
出版商
Korean Society for Bone and Mineral Research
发表日期
2021-06-09
DOI
10.11005/jbm.2021.28.2.115
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Hip fracture care during Covid-19: a regional trauma centre’s experience
- (2021) Geoff Crozier-Shaw et al. IRISH JOURNAL OF MEDICAL SCIENCE
- Implementation of an integrated care programme to avoid fragility fractures of the hip in older adults in 18 Bavarian hospitals – study protocol for the cluster-randomised controlled fracture liaison service FLS-CARE
- (2021) Isabel Geiger et al. BMC Geriatrics
- Virtual fracture liaison clinics in the COVID era: an initiative to maintain fracture prevention services during the pandemic associated with positive patient experience
- (2021) S. English et al. OSTEOPOROSIS INTERNATIONAL
- How has COVID-19 affected the treatment of osteoporosis? An IOF-NOF-ESCEO global survey
- (2021) N. R. Fuggle et al. OSTEOPOROSIS INTERNATIONAL
- Osteoporosis care amidst the prolonged pandemic
- (2021) R. R. Narla et al. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
- Poor adherence to parenteral osteoporosis therapies during COVID-19 pandemic
- (2021) Roland Kocijan et al. Archives of Osteoporosis
- Increased 30-day mortality rate in patients admitted with hip fractures during the COVID-19 pandemic in the UK
- (2021) Thomas Barker et al. European Journal of Trauma and Emergency Surgery
- Vaccination for Coronavirus Disease 2019 ( COVID ‐19) and Relationship to Osteoporosis Care: Current Evidence and Suggested Approaches
- (2021) Elena Tsourdi et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Delayed hospital admission for traumatic hip fractures during the COVID-19 pandemic
- (2021) Stephanie Jarvis et al. Journal of Orthopaedic Surgery and Research
- Secondary prevention of fragility fractures: where do we stand during the COVID-19 pandemic?
- (2021) A. Falchetti et al. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
- A Single Infusion of Zoledronate in Postmenopausal Women Following Denosumab Discontinuation Results in Partial Conservation of Bone Mass Gains
- (2020) Judith Everts‐Graber et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Risk for Infections During Treatment With Denosumab for Osteoporosis: a Systematic Review and Meta-analysis
- (2020) Talia Diker-Cohen et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Efficacy and safety of Romosozumab in treatment for low bone mineral density: a systematic review and meta-analysis
- (2020) Sara Kaveh et al. CLINICAL RHEUMATOLOGY
- Endocrinology in the time of COVID-19: Management of calcium disorders and osteoporosis
- (2020) Neil J Gittoes et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Osteoporosis Management in the Era of COVID ‐19
- (2020) Elaine W Yu et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Effects of follow-on therapy after denosumab discontinuation in patients with postmenopausal osteoporosis
- (2020) Kosuke Ebina et al. Modern Rheumatology
- Corticosteroid‐Induced Osteonecrosis in COVID ‐19: A Call For Caution
- (2020) Bin Zhang et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Osteoporotic Fractures in the Time of COVID ‐19
- (2020) Timothy Bhattacharyya JOURNAL OF BONE AND MINERAL RESEARCH
- Fracture risk and management of discontinuation of denosumab therapy: a systematic review and position statement by ECTS
- (2020) Elena Tsourdi et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Global impact of COVID-19 on non-communicable disease management: descriptive analysis of access to FRAX fracture risk online tool for prevention of osteoporotic fractures
- (2020) E. V. McCloskey et al. OSTEOPOROSIS INTERNATIONAL
- COVID-19: Second Wave or Multiple Peaks, Natural Herd Immunity or Vaccine—We Should be Prepared
- (2020) Rima Moghnieh et al. Disaster Medicine and Public Health Preparedness
- A Review of the Pharmacological Properties of Psoralen
- (2020) Yali Ren et al. Frontiers in Pharmacology
- The impact of lockdown during the COVID-19 pandemic on osteoporotic fragility fractures: an observational study
- (2020) Giulia Ogliari et al. Archives of Osteoporosis
- A systematic review and meta-analysis of the effect of bisphosphonate drug holidays on bone mineral density and osteoporotic fracture risk
- (2019) S. Nayak et al. OSTEOPOROSIS INTERNATIONAL
- Zoledronate for the Prevention of Bone Loss in Women Discontinuing Denosumab Treatment. A Prospective 2‐year Clinical Trial
- (2019) Athanasios D. Anastasilakis et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Bone Mineral Density After Transitioning From Denosumab to Alendronate
- (2019) David Kendler et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- ACUTE PHASE REACTIONS AFTER ZOLEDRONIC ACID INFUSION: PROTECTIVE ROLE OF 25-HYDROXYVITAMIN D AND PREVIOUS ORAL BISPHOSPHONATE THERAPY
- (2018) Chiara Crotti et al. Endocrine Practice
- Effects of 24 Months of Treatment With Romosozumab Followed by 12 Months of Denosumab or Placebo in Postmenopausal Women With Low Bone Mineral Density: A Randomized, Double-Blind, Phase 2, Parallel Group Study
- (2018) Michael R McClung et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Effects of teriparatide and risedronate on new fractures in post-menopausal women with severe osteoporosis (VERO): a multicentre, double-blind, double-dummy, randomised controlled trial
- (2018) David L Kendler et al. LANCET
- Effects of bone remodeling agents following teriparatide treatment
- (2018) D. Burkard et al. OSTEOPOROSIS INTERNATIONAL
- Vertebral Fractures After Discontinuation of Denosumab: A Post Hoc Analysis of the Randomized Placebo-Controlled FREEDOM Trial and Its Extension
- (2017) Steven R Cummings et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Clinical Features of 24 Patients With Rebound-Associated Vertebral Fractures After Denosumab Discontinuation: Systematic Review and Additional Cases
- (2017) Athanasios D Anastasilakis et al. JOURNAL OF BONE AND MINERAL RESEARCH
- High-Intensity Resistance and Impact Training Improves Bone Mineral Density and Physical Function in Postmenopausal Women With Osteopenia and Osteoporosis: The LIFTMOR Randomized Controlled Trial
- (2017) Steven L Watson et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Romosozumab or Alendronate for Fracture Prevention in Women with Osteoporosis
- (2017) Kenneth G. Saag et al. NEW ENGLAND JOURNAL OF MEDICINE
- Factors associated with acute-phase response of bisphosphonate-naïve or pretreated women with osteoporosis receiving an intravenous first dose of zoledronate or ibandronate
- (2017) A.W. Popp et al. OSTEOPOROSIS INTERNATIONAL
- Effect of single-dose dexamethasone on acute phase response following zoledronic acid: a randomized controlled trial
- (2017) E. O. Billington et al. OSTEOPOROSIS INTERNATIONAL
- 10 years of denosumab treatment in postmenopausal women with osteoporosis: results from the phase 3 randomised FREEDOM trial and open-label extension
- (2017) Henry G Bone et al. Lancet Diabetes & Endocrinology
- Romosozumab Treatment in Postmenopausal Women with Osteoporosis
- (2016) Felicia Cosman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Daily or Cyclical Teriparatide Treatment in Women With Osteoporosis on no Prior Therapy and Women on Alendronate
- (2015) Felicia Cosman et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Denosumab and teriparatide transitions in postmenopausal osteoporosis (the DATA-Switch study): extension of a randomised controlled trial
- (2015) Benjamin Z Leder et al. LANCET
- Management of the Elderly With Vertebral Compression Fractures
- (2015) Christina L. Goldstein et al. NEUROSURGERY
- Acute phase response following intravenous zoledronate in postmenopausal women with low bone mass
- (2012) Athanasios D. Anastasilakis et al. BONE
- No Effect of Rosuvastatin in the Zoledronate-Induced Acute-Phase Response
- (2011) Polyzois Makras et al. CALCIFIED TISSUE INTERNATIONAL
- The effect of 3 versus 6 years of Zoledronic acid treatment of osteoporosis: A randomized extension to the HORIZON-Pivotal Fracture Trial (PFT)
- (2011) Dennis M Black et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Effects of Denosumab Treatment and Discontinuation on Bone Mineral Density and Bone Turnover Markers in Postmenopausal Women with Low Bone Mass
- (2011) Henry G. Bone et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Final results of the DAPS (Denosumab Adherence Preference Satisfaction) study: a 24-month, randomized, crossover comparison with alendronate in postmenopausal women
- (2011) N. Freemantle et al. OSTEOPOROSIS INTERNATIONAL
- Characterization of and Risk Factors for the Acute-Phase Response after Zoledronic Acid
- (2010) I. R. Reid et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Effect of Denosumab on Bone Mineral Density and Biochemical Markers of Bone Turnover: Six-Year Results of a Phase 2 Clinical Trial
- (2010) Paul D. Miller et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Effects of Teriparatide Treatment and Discontinuation in Postmenopausal Women and Eugonadal Men with Osteoporosis
- (2009) Benjamin Z. Leder et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Bisphosphonate binding affinity as assessed by inhibition of carbonated apatite dissolutionin vitro
- (2007) Zachary J. Henneman et al. JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started